You are here

  • Home
  • Archive
  • Volume 8, Issue 10
  • Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink

Article metrics

Article menu

Download PDFPDF

XML
Diabetes and endocrinology
Research
Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink

 

Online download statistics by month:

Online download statistics by month: October 2018 to June 2025

AbstractFullPdf
Oct 201841841089
Nov 201819318625
Dec 201819819511
Jan 2019807615
Feb 2019706510
Mar 2019555512
Apr 2019363421
May 2019313024
Jun 2019131315
Jul 2019151514
Aug 2019212120
Oct 2019171729
Nov 2019323115
Dec 2019181821
Jan 2020171710
Feb 2020313130
Mar 2020151522
May 202019199
Jun 2020121018
Jul 2020201724
Aug 2020121012
Sep 2020212115
Oct 2020242121
Nov 2020191630
Dec 2020313021
Jan 2021302423
Feb 2021292628
Mar 2021443929
Apr 2021141422
May 2021171636
Jun 2021272537
Jul 2021201926
Aug 20217631
Sep 2021222726
Oct 2021202837
Nov 2021172918
Dec 202110206
Jan 202214247
Feb 2022141720
Mar 2022252713
Apr 2022829424
May 2022481829
Jun 2022312227
Jul 2022251721
Aug 2022221195
Sep 2022231439
Oct 2022231834
Nov 2022201628
Dec 2022242429
Jan 2023807754
Feb 2023252441
Mar 2023332836
Apr 2023242352
May 2023141070
Jun 2023252475
Jul 20238873453
Aug 20234029180
Sep 20234839179
Oct 20239681180
Nov 20238956100
Dec 2023795775
Jan 2024452924
Feb 2024714448
Mar 2024433482
Apr 2024493854
May 2024574444
Jun 2024393544
Jul 2024513932
Aug 2024393522
Sep 2024545037
Oct 2024494341
Nov 20248473113
Dec 2024745640
Jan 2025424137
Feb 202510310019
Mar 2025837128
Apr 2025797534
May 2025463630
Jun 2025272119
Total370233333461